Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL416239

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
O=C(NCc1ccccc1)N[C@@H](CNC(=O)c1cc2n(n1)CCN(CCC1CCNCC1)C2=O)C(=O)O

Basic Information

ChEMBL ID CHEMBL416239
Phase Preclinical
Structure Type MOL
InChI Key YWXJVOYLQXXBSX-FQEVSTJZSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

511.6
MW (Da)
0.41
ALogP
7
HBA
5
HBD
157.7
PSA (Ų)
0.31
QED
1
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C25H33N7O5
MW 511.58
Aromatic Rings 2
Heavy Atoms 37
NP-Likeness -1.08

Activity Summary

IC50 1 meas. best 7.66

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Homo sapiens
CHEMBL372
IC50 7.66 7.66 22.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Homo sapiens IC50 = 22.0 nM 7.66 Concentration required for 50% inhibition of platelet aggregation of human gel-f... -

Literature References

PubMed DOI Target Context # Activities
- 10.1016/S0960-894X(97)00256-4 Homo sapiens 1

Data from ChEMBL 36 via Core Engine